Search

Your search keyword '"Laune, D."' showing total 387 results

Search Constraints

Start Over You searched for: Author "Laune, D." Remove constraint Author: "Laune, D."
387 results on '"Laune, D."'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

4. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

6. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

9. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

10. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

11. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

12. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

13. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

14. Work productivity in rhinitis using cell phones: The MASK pilot study

15. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

16. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework

17. Development and validation of combined symptom-medication scores for allergic rhinitis*

18. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

19. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

20. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

21. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

22. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

23. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

24. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

25. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

26. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

27. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

28. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

29. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

30. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

31. Is diet partly responsible for differences in COVID-19 death rates between and within countries? (vol 10, 16, 2020)

32. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

33. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

34. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

35. Treatment of allergic rhinitis during and outside the pollen season using mobile technology : A MASK study

36. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

37. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

38. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

41. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases

42. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

43. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

44. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

45. 2019 ARIA Care pathways for allergen immunotherapy

46. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

47. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

48. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

49. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

50. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

Catalog

Books, media, physical & digital resources